Therapeutically dosed low molecular weight heparins in renal impairment: a nationwide survey.
Tessa Corrine Catherina JaspersA KeyanyB MaatK MeijerP M L A van den BemtN KhorsandPublished in: European journal of clinical pharmacology (2022)
Treatment policies show substantial diversity in therapeutically dosed LMWHs in renally impaired patients. The most commonly used treatment regimen was a regular dose reduction if eGFR is < 50 ml/min, without anti-Xa monitoring.